FxMed Competitors

At Zywave, we don’t just build technology—we amplify impact. Our work empowers insurers and brokers to protect people and businesses when they need it most. Join us in shaping the future of insurance. Only Zywave delivers a powerful Performance Multiplier, bringing together transformative, ecosystem-wide capabilities to amplify impact across data, processes, people, and customer experiences. With Zywave, insurers and brokers can continuously calibrate their business to get risk right, elevate human performance, and scale their business at unprecedented speed amid growing uncertainty, ever-evolving risk, and structural economic change. Our people power the Performance Multiplier. Zywave fosters a culture of collaboration, continuous learning, and bold thinking to drive meaningful results. United States & Canada: 877-699-9928 or marketing@zywave.com United Kingdom: 0800 048 8648 or marketing@zywave.com Recruiting: recruiting@zywave.com

Douglas Pharmaceuticals is a New Zealand success story – a family-owned pharmaceutical company with a reputation for high manufacturing standards, quality products and outstanding client service. Through our contract development and manufacturing business, Douglas CDMO, we offer our expertise, unwavering attention, dedication, and leading technology. We partner with biotechnology and pharmaceutical companies to successfully bring their products to life and out to market. Learn more at www.douglascdmo.com. At Douglas, our mission is to improve lives. We’re proud of our world class research, our products and our technology. Our talented team works with innovative partners to research and develop, manufacture, market and distribute pharmaceutical products around the world. Every day, our 500 people innovate, collaborate, and grow with a company that puts people first, while supporting and challenging them to do their life’s best work.

Back in 1997, husband and wife team Hartley and Marree Atkinson hit the road selling products direct to pharmacies. AFT Pharmaceuticals was formed with a big dream in mind. In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala Lumpur, Sydney and Auckland (our HQ). We export or license our products to over 109 countries. Plus our Orphan Drugs Foundation provides access to lower cost pharmaceuticals for people with rare diseases within South East Asia and the Pacific. This success has been built on research and development. R&D is more than corporate speak for us. It’s at the heart of what we do, whether it’s developing new products, or improving existing existing ones. It’s also due to the fact that we are close to the market. Because we sell our own products we are constantly looking for changes in health needs and how we can fill gaps that emerge. Our ideas, our researchers, our specialist drug development programmes, and the international experts we partner with have allowed us to grow year on year. It’s how we’ve managed to forge a place on the world stage in the extremely competitive pharmaceutical industry. We're proud of our past achievements. We’re ambitious for the future.